Comparative genomic hybridization analysis of hepatoblastomas

Genes Chromosomes and Cancer

Volumn 27, Issue 2, 2000, Pages 196-201

  Hu, Jie ^a   Wills, Marcia ^a   Baker, Barbara A ^a   Perlman, Elizabeth J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 4; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE AMPLIFICATION; GENE LOCUS; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; NUCLEIC ACID HYBRIDIZATION;

EID: 0033985988     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200002)27:2<196::AID-GCC12>3.0.CO;2-D     Document Type: Article

References (49)

1. Adelaide J, Chaffanet M, Imbert A, Allione F, Geneix J, Popovici C, van Alewijk D, Trapman J, Zeillinger R, Borresen-Dale A, Lidereau R, Birnbaum D, Pebusque M. 1998. Chromosome region 8p11-p21: refined mapping and molecular alterations in breast cancer. Genes Chromosomes Cancer 22:186-199.
2. Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Deimling A, Pietsch T. 1994. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res 1994 54:5041-5044.
3. Anneren G, Nordlinder H, Hedborg F. 1992. Chromosome aberrations in an alpha fetoprotein-producing hepatoblastoma. Genes Chromosomes Cancer 4:99-100.
4. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
5. Bardi G, Johnasson B, Pandis N, Bekassy AN, Kullendorf CM, Hagerstrand I, Heim S. 1991. i(8q) as the primary structural chromosome abnormality in a hepatoblastoma. Cancer Genet Cytogenet 51:281-283.
6. Bardi G, Johnasson B, Pandis N, Heim S, Mandahl N, Bekassy A, Hagers-Trand I, Mitelman I. 1992. Trisomy 2 as the sole chromosome abnormality in a hepatoblastoma. Genes Chromosomes Cancer 4:78-80.
7. Bernstein IT, Bulow S, Mauritzen K. 1992. Hepatoblastoma in two cousins in a family with adenomatous polyposis: report of two cases. Dis Colon Rectum 35:373-374.
8. Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW, Benz CC. 1997. ESX: a structural unique Ets over expressed early during human breast tumorigenesis. Oncogene 14:1617-1622.
9. DeBaun MR, Tucker MA. 1998. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry. J Pediatr 132:398-400.
10. Douglass EC, Green AA, Hayes FA, Etcubanas E, Horowitz M, Wilmas JA. 1985. Chromosome 1 abnormalities: a common feature for pediatric solid tumors. J Natl Cancer Inst 75:51-54.
11. Fletcher JA, Kozakewich HP, Pavelka K, Grier HE, Shamberger RC, Korf B, Morton CC. 1991. Consistent cytogenetic aberrations in hepatoblastoma: a common pathway of genetic alterations in embryonal liver and skeletal muscle malignancies? Genes Chromosomes Cancer 3:37-43.
12. Fujiwara Y, Emi M, Ohata H, et al. 1993. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res 53:1172-1174.
13. Garber JE, Li FP, Kinston JE, Krush AJ, Strong LC, Finegold MJ, Bertario L, Bulow S, Filippone A, Gedde-Dahl T, et al. 1989. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst 80:1626-1628.
14. Giardello FM, Petersen GM, Brensinger JD, Luce MC, Cayouette MC, Bacon J, Booker SV, Hamilton SR. 1991a. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 39:867-869.
15. Giardello FM, Offerhaus GJ, Krush AJ, Booker SV, Tersmette AC, Mulder JW, Kelley CN, Hamilton SR. 1991b. Risk of hepatoblastom in familial adenomatous polyposis. J Pediatr 119:766-768.
16. Habuchi T, Kinoshita H, Yamada H, Kakehi Y, Ogawa O, Wu WJ, Takahashi R, Sugiyama T, Yoshida O. 1994. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification. J Nat Cancer Inst 86:1331-1335.
17. Haupt Y, Maya R, Kazaz A, Oren M. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
18. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. 1985. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 316:330-334.
19. Kurahashi H, Takami K, Que T, Kusafuka T, Okada A, Tawa A, Okada S, Nishisho I. 1995. Biallelic inactivation of the APC gene in hepatoblastoma. Cancer Res 55:5007-5011.
20. Kusafuka T, Fukuzawa M, Oue T, Komoto Y, Yoneda A, Okoda A. 1997. Mutation analysis of p53 gene in childhood malignant solid tumors. J Pediatr Surg 32:1175-1180.
21. Leyns L, Bouwmeester T, Kim SH, Piccolo S, De RE. 1997. Frzb-1 is a secreted antoagonist of Wnt signaling expressed in the Spemann organizer. Cell 88:747-756.
22. Li FP, Thurber WA, Seddon J, Holmes GH. 1987. Hepatoblastomas in families of polyposis coli. JAMA 257:2475-2477.
23. Lianes P, Orlow I, Zhang ZF, Oliva MR, Sarkis AS, Renter VE Cordoncardo C. 1994. Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst 86:1325-1330.
24. Mascarello JT, Jones MC, Kadota RP, Krous HF. 1990. Hepatoblastoma characterized by trisomy 20 and double minutes. Cancer Genet Cytogenet 47:243-247.
25. Muller-Pillasch F, Zimmerhackl F, Lancher U, Schultz N, Hameister H, Varga G, Friess H, Buchler M, Adler G, Gress TM. 1997. Cloning of novel transcripts of the human guanine-nucleotide-exchange factor Mss4: in situ chromosomal mapping and expression in pancreatic cancer. Genomics 46:389-396.
26. Oda H, Imai Y, Nakatsuru Y, Hata J, Ishikawa T. 1996. Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res 56:3320-3322.
27. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. 1992. Amplification of a p53-associated protein in human sarcomas. Nature 358:80-83.
28. Petkovic I, Nakic M, Cepulic M. 1985. Cytogenetic analysis of hepatoblastoma. Cancer Genet Cytogenet 15:369-371.
29. Rainier S, Dobry CJ, Feinberg AP. 1995. Loss of imprinting in hepatoblastoma. Cancer Res 55:1836-1838.
30. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Colins VP. 1993. Amplification and over expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739.
31. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S, Cremer T. 1994. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54:1801-1806.
32. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham, C, Blegen H, Zetterberg A, Cremer T, Auer G. 1995. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55:5415-5423.
33. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G. 1996. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes and Cancer 15:234-245.
34. Rothe M, Xiong J, Shu HB, Williamson K, Goddard A, Goeddel DV. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediatcd signal transduction. Proc Natl Acad Sci 93:8241-8246.
35. Saijo M, Sakai V, Kishino T, Niikawa N, Matsuura Y, Morino K, Tamai K, Taya Y. 1995. Molecular cloning of a human protein that binds to the retinoblastoma protein and chromosomal mapping. Genomics 27:511-519.
36. Schneider NR, Cooley LD, Finegold MJ, Douglass EC, Tomlinson GE. 1997. The first recurring chromosome translocation in hepatoblastoma: der(4)t(1:4)(q12;q34). Genes Chromosomes Cancer 19: 291-294.
37. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffer MC, Jauch A, Speicher MR, Murnberg P, Vogel S, Janisch W, Donis-Keller H, Ried T, Witkoski R, Cremer T. 1994. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and non random chromosomal gains and losses. Am J Pathol 144:1203-1218.
38. Sen S, Zhou H, White RA. 1997. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in breast cancer cell lines. Oncogene 14:2195-2200.
39. Shimizu F, Katagiri T, Suzuki M, Watanabe TK, Okuno S, Kuga Y, Nagata M, Fugiwara T, Nakamura Y, Takahashi E. 1997. Cloning and chromosome assignment to 1q32 of a human cDNA(RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily. Cytogenet Cell Genet 77:261-263.
40. Shvarts A, Bazuine M, Dekker P, Ramos YE, Steengenga WT, Merckx G, van der Eb AJ, van der Houven van Oordt W, Jochemsen AG. 1997. Isolation and identification of human homolog of a new p53-binding protein, Mdmx. Genomics 43:34-42.
41. Soukup SW, Lampkin BL. 1991. Trisomy 2 and 20 in two hepatoblastomas. Genes Chromosomes Cancer 3:231-234.
42. Swarts S, Wisecarver J, Bridge JA. 1996. Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma. Cancer Genet Cytogenet 91:65-67.
43. Tanner MM, Tirkkonen M, Kallioniemi A, Holli K, Collins C, Kowbel D, Gray JW, Kallioniemi OP, Isola J. 1995. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res 1:1455-1461.
44. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi OP. 1996. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
45. Tapper J, Sarantaus, Vahteristo P, Nevanlinna H, Hemmer S, Seppala M, Knuutila S, Butzow R. 1998. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32. Cancer Res 58:2715-2719.
46. ten Dijke P, Ichijo H, Franzen P Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K. 1993. Activin receptor-like kinases: a novel sublass of cell-surface receptors with predicted serine/ threonine kinase activity. Oncogene 8:2879-2887.
47. Tonk VS, Wilson KS, Timmons CF, Schneider NR. 1994. Trisomy 2, trisomy 20, and del(17p) as sole chromosomal abnormalities in three cases of hepatoblastoma. Genes Chromosomes Cancer 11:199-202.
48. Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT. 1994. Loss of heterozygosity of chromosme 8 microsatellite loci implicates a candidate tumor suppressor gene between D8S87 and D8S133 in human prostate cancer. Cancer Res 54:6061-6064.
49. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R. 1996. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14:430-440.